Myrbetriq and Device dislocation - a phase IV clinical study of FDA data

Summary:

Device dislocation is reported as a side effect among people who take Myrbetriq (mirabegron), especially for people who are male, 60+ old, have been taking the drug for 1 - 6 months also take Duopa, and have Parkinson's disease.

The phase IV clinical study analyzes which people have Device dislocation when taking Myrbetriq. It is created by eHealthMe based on reports of 33,382 people who have side effects when taking Myrbetriq from the FDA, and is updated regularly.

What is Myrbetriq?

Myrbetriq has active ingredients of mirabegron. It is often used in urge incontinence. eHealthMe is studying from 33,658 Myrbetriq users. Check the latest studies of Myrbetriq.

What is Device dislocation?

Device dislocation is found to be associated with 703 drugs and 707 conditions by eHealthMe. Check the latest studies of Device dislocation.

On Jul, 10, 2026

33,382 people reported to have side effects when taking Myrbetriq.
Among them, 66 people (0.2%) have Device dislocation.

Could Myrbetriq cause Device dislocation?

Among these 66 people:

How long have people been on Myrbetriq when they have Device dislocation? *

What is the gender of people who have Device dislocation when taking Myrbetriq? *

female: 40.32 %
male: 59.68 %

What is the age of people who have Device dislocation when taking Myrbetriq? *

What are other drugs people take besides Myrbetriq? *

What are other side effects people have besides Device dislocation? *

Fall: 31 people, 46.97%
Speech Disorder: 14 people, 21.21%
Urinary Tract Infection: 14 people, 21.21%
Tremor (trembling or shaking movements in one or more parts of your body): 11 people, 16.67%
Fatigue (feeling of tiredness): 10 people, 15.15%
Weakness: 10 people, 15.15%
Neuropathy Peripheral (surface nerve damage): 10 people, 15.15%
Muscle Tightness: 10 people, 15.15%
Loss Of Bladder Sensation (can not feel the urge of urination): 9 people, 13.64%
Myasthenia Gravis (a chronic condition that causes muscles to tire and weaken easily): 9 people, 13.64%

What are the existing conditions these people have? *

Parkinson's Disease: 35 people, 53.03%
Bladder Spasm: 9 people, 13.64%
Encephalitis Autoimmune (autoimmune origin disturbances of consciousness and pyramidal signs, inflammation of the brain): 9 people, 13.64%
Sleep Disorder: 9 people, 13.64%
Restless Leg Syndrome (a powerful urge to move your legs): 7 people, 10.61%
Depression: 6 people, 9.09%
Urinary Tract Infection: 6 people, 9.09%
Hypertonic Bladder (bladder-storage function that causes a sudden urge to urinate): 5 people, 7.58%
Pain: 5 people, 7.58%
Hallucinations (sensations that appear real but are created by your mind): 4 people, 6.06%

* Approximation only. Some reports may have incomplete information.

Do you take Myrbetriq and have Device dislocation?

- Check whether Device dislocation is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Myrbetriq:

Myrbetriq (33,658 reports)

Browse all side effects of Myrbetriq:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Device dislocation:

Device dislocation (703 drugs)

Browse all the conditions that are associated with Device dislocation:

Device dislocation (707 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on mirabegron (the active ingredients of Myrbetriq) and Myrbetriq (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.